These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1210 related items for PubMed ID: 19443599

  • 21. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Rand T, Loewe C, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, Wolf F, Schneider B, Lammer J.
    Cardiovasc Intervent Radiol; 2005; 28(3):313-8. PubMed ID: 15886943
    [Abstract] [Full Text] [Related]

  • 22. [The treatment of hepatocellular carcinoma by chemoembolization].
    Marchiori L, Mansueto GC, Nifosi F, Bortolasi L, Dal Dosso I, Facci E, Perus G, Nicoli N.
    Chir Ital; 1994; 46(1):17-22. PubMed ID: 8025966
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H.
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [Abstract] [Full Text] [Related]

  • 25. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M, Esmaeel M, El-Khodary T, Awad M, Amer T.
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [Abstract] [Full Text] [Related]

  • 26. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.
    J Hepatobiliary Pancreat Surg; 2008 Sep; 15(6):627-33. PubMed ID: 18987934
    [Abstract] [Full Text] [Related]

  • 27. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [Abstract] [Full Text] [Related]

  • 28. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.
    Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT.
    Cancer; 2009 Dec 01; 115(23):5507-15. PubMed ID: 19701904
    [Abstract] [Full Text] [Related]

  • 29. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
    Giannini EG, Bodini G, Corbo M, Savarino V, Risso D, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F, ITALIAN LIVER CANCER (ITA.LI.CA.) GROUP.
    Aliment Pharmacol Ther; 2010 Feb 15; 31(4):493-501. PubMed ID: 19912152
    [Abstract] [Full Text] [Related]

  • 30. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 31. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb 01; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 32. [Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience].
    Savastano S, Feltrin GP, Miotto D, Chiesura-Corona M, Torraco A, Castellan L, Roman E, el Khatib AB, Cannito F, Sandri P.
    Radiol Med; 1992 Nov 01; 84(5):608-12. PubMed ID: 1335590
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 01; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim SH, Chung YH, Yang SH, Kim JA, Jang MK, Kim SE, Lee D, Lee SH, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Suh DJ.
    Korean J Hepatol; 2009 Sep 01; 15(3):320-30. PubMed ID: 19783881
    [Abstract] [Full Text] [Related]

  • 35. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2004-11. PubMed ID: 21621346
    [Abstract] [Full Text] [Related]

  • 36. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K.
    Hepatogastroenterology; 2003 Apr 01; 50(51):809-13. PubMed ID: 12828090
    [Abstract] [Full Text] [Related]

  • 37. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003 Apr 01; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 38. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, Schoenberg SO, Diehl SJ.
    Onkologie; 2010 Apr 01; 33(1-2):31-7. PubMed ID: 20164659
    [Abstract] [Full Text] [Related]

  • 39. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M, Bonnetain F, Bouché O, Vetter D, Abergel A, Fratté S, Grangé JD, Stremsdoerfer N, Blanchi A, Bronowicki JP, Caroli-Bosc FX, Causse X, Masskouri F, Rougier P, Bedenne L, Fédération Francophone de Cancérologie Digestive.
    Eur J Cancer; 2008 Mar 01; 44(4):528-38. PubMed ID: 18242076
    [Abstract] [Full Text] [Related]

  • 40. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y, Lang QB, Chen Z, Li B, Yu CQ, Zhu DZ, Huang XQ, Zhai XF, Ling CQ.
    Chin Med J (Engl); 2009 Sep 05; 122(17):1990-5. PubMed ID: 19781383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.